Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 46Gynecologic 34CNS 10Thoracic 9Other solid neoplasm 6Sarcoma 5Tumor-Agnostic 4Head & Neck 3Genitourinary 3Breast 2NET 1Endocrine 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Ovarian Neoplasms 1Melanoma 1Endometrial Neoplasms 1Chondrosarcoma 1

Interventions

Nivolumab 24pembrolizumab 21Specimen Handling 17Ipilimumab 16Magnetic Resonance Spectroscopy 11CTLA-4 Antigen 8Opdualag 6Cyclophosphamide 6Biopsy 6trametinib 5relatlimab 5binimetinib 5fludarabine phosphate 4fludarabine 4dabrafenib 4cemiplimab 4atezolizumab 4X-Rays 4Paclitaxel 4Immunoglobulin G 4Disulfides 4Temozolomide 3Standard of Care 3Introns 3Interferon alpha-2 3Gemcitabine 3Carboplatin 3Blood Specimen Collection 3ulixertinib 2sargramostim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bevacizumab × Dermatologic × 30 days × Clear all
NCT05039801 2026-06-01

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Recruiting
54 enrolled
DermatologicGynecologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Chondrosarcoma, Melanoma, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡